Saudi, UAE VAT may adversely affect majority of Indian expats

Ballari, Jan 5: Thousands of Muslims, joined by the members of various organisations, on Saturday staged a massive protest in the town condemning the provocative speech by Bellary MLA G Somashekar Reddy.

The police caned the agitators after they tried to lay siege to the house of BJP legislator.

The protesters holding national flag took out a rally from Kaul Bazaar, which passed through the major streets, and culminated at Gadagi Channappa Circle. They raised slogans against the BJP and burnt the effigy of Somashekar Reddy.

The protest sent the traffic haywire Gadagi Channappa Circle and the cascading effect of it was seen across the town. SP C K Babu told the agitators that the MLA has been booked for making provocative speech and pleaded them to hold a protest at Municipal College grounds. But the agitators were in no mood to relent.

Inspector General (Bellary Range) I G Nanjundaswamy has rushed to the town to oversee security. The BJP MLA on Friday made inciting remarks against minorities during his speech at a pro-CAA rally in the town.

FIR against Reddy

The Gandhinagar police in the town on Saturday registered an FIR against MLA Somashekar Reddy, for making a provocative speech, under IPC Sections 153 A (promoting enmity between two religions), 295A (insulting religious beliefs) and 505B.

During his speech at a pro-CAA rally on Friday, Reddy had said, "Hindus are 80% of the population while minorities are 17%. What will happen to you if we hit back? Hence, you should be very careful about your moves and steps."

The legislator came down heavily on those staging protests against CAA in Ballari. "We won't keep quiet if another protest is staged against the CAA. Each Hindu is like Shivaji. Nobody will be alive if all Hindus come out to streets holding swords," he had said.

Udupi, Feb 23: Tanushree Pithrody, a 10-year-old girl from Udyavar and class 6 student of St Cecily’s School, here and a Guinness World Record holder, erased the old record by covering the 100 metres 'Chakrasana race' in one minute 14 seconds to write her name in the Golden Book of World Records.

This was announced by Manish Bishnoi, Head, Golden Book of World Records, who handed over the Certificate to Ms Tanushree, who was accompanied by her father Uday Kumar and mother Sandhya here on Saturday.

The previous record-holder in this category was Samiksha Dogra [11 years and 1 month] from Rampur Bhushar, Himachal Pradesh, who had set a time of 6 minutes and 2 seconds on June14,2018.

Later speaking to scribes here, Ms Tanushree said that she was delighted that she was able to break the record. “When I was practicing, I used to finish it in around 2 minutes. This is my fifth record. I dedicate my success to my parents and my Yoga guru,”she added.

Ms Tanushree has also created a record for the ‘most forward rolls with Dhanurasana Yoga pose in 1 minute’ by performing 62 rolls and she also created the ‘fastest 100 forward rolls with Dhanurasana Yoga pose’ in 1 minute and 40 seconds on February 23, 2019 and entered the Golden Book of World Records.

In 2018, she set the Guinness World Record for ‘most full-body revolutions maintaining a chest stand position’ with 42 full-body revolutions in one minute, and on 21 March, 2019 she broke that record with 44.

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.